Sanofi SA has synthesized pyridoimidazolone compounds acting as mitogen-activated protein kinase 7 (MAPK7; ERK5) inhibitors potentially useful for the treatment of cancer.
(Alliance News) - Poolbeg Pharma PLC on Wednesday announced its immunomodulator I patent has been granted in the US. The London-based clinical stage biopharmaceutical company targeting diseases with a ...
Trump Vows to Hit Mexico, Canada and China With Tariff on Day 1 President-elect Trump promised a 25 percent tariff on Canada and Mexico, and an additional 10 percent on China, blaming the flow of ...
Most human pre-implantation are mosaics of euploid and aneuploid cells, however, mosaic embryos with a low proportion of aneuploid cells have a similar likelihood of developing to term as fully ...